Migraine Pharmacology Flashcards
Ergot alkaloids used to in treatment of migraine
Dihydroergotamine (DHE)
Ergotamine + caffeine
Triptans used in the treatment of migraine
Sumatriptan Almotriptan Naratriptan Zolmitriptan Rizatriptan Eletriptan Frovatriptan
Beta blockers used in prevention of migraine
Propranalol
Timolol
Tricyclic antidepressants used in prevention of migraine
Amitriptyline
Imipramine
Anticonvulsants used for migraine prevention
Topiramate
Valproate
Calcium channel blocker used for migraine prevention
Verapamil
In what case is Botox considered as a therapeutic option for migraine?
Chronic migraine only — 15+ days/month with headache lasting 4+ hours/day in people age 18+
MOA of Botox used for treatment of chronic migraine
Botox neurotoxin cleaves SNAP-25 in motor neurons which inhibits ACh release at the motor endplate —> reduced muscle activity
Migraines are considered neurovascular headaches in that neural events result in _____ of blood vessels resulting in pain and further nerve activation
The meninges sense pain due to their innervation by _____ axons
Vasodilation; trigeminal
During a migraine headache, mediators are released which potentiate the disease process.
______ is released from trigeminal Ad-fibers which increases dural vessel vasodilation
____ and ____ are released from trigeminal C-fibers and increase dural vessel permeability
CGRP
Substance P; neurokinin A
Why might organic nitrates (NO— used to treat coronary artery disease) provoke migraine?
NO causes release of CGRP in vessels and nerves
During a migraine, brainstem dysfunction sparks a wave of excitation and depression in the cortex termed _______ ______ ______, which leads to cerebral _________
This process is accompanied by H+, K+, and NO discharge from neurons
Cortical spreading depression (CSD); vasoconstriction
Cranial vessels and presynaptic trigeminal nerve terminals express a subset of _____ receptors, which modulate the actions of CGRP. _____ are selective agonists at these receptors (specifically ____ and _____), making them more effective than ergot alkaloids
Serotonin; Triptans; Vascular 5HT-1B; Synaptic 5HT-1D
Describe Triptans effects on binding to 5HT-1B receptors
Triptans binding to 5HT-1B receptors on vascular smooth muscle stimulates vasoconstriction of dilated meningeal, dural, and pial blood vessels
Describe Triptans effects on binding to 5HT-1D receptors
Triptans binding to 5HT-1D receptors on presynaptic nerve terminals inhibits presynaptic release of CGRP and other neuropeptides from the peripheral end of the trigeminal n.
Triptans binding to 5HT-1D receptors on trigeminal nucleus in the brainstem modulates incoming painful sensory info from the periphery, and inhibits upward transmission of painful sensory info to the thalamus and higher brain centers where pain is perceived